Identification of Traditional Medicinal Plant Extracts with Novel Anti-Influenza Activity

Abstract

The emergence of drug resistant variants of the influenza virus has led to a need to identify novel and effective antiviral agents. As an alternative to synthetic drugs, the consolidation of empirical knowledge with ethnopharmacological evidence of medicinal plants offers a novel platform for the development of antiviral drugs. The aim of this study was to identify plant extracts with proven activity against the influenza virus. Extracts of fifty medicinal plants, originating from the tropical rainforests of Borneo used as herbal medicines by traditional healers to treat flu-like symptoms, were tested against the H1N1 and H3N1 subtypes of the virus. In the initial phase, in vitro micro-inhibition assays along with cytotoxicity screening were performed on MDCK cells. Most plant extracts were found to be minimally cytotoxic, indicating that the compounds linked to an ethnomedical framework were relatively innocuous, and eleven crude extracts exhibited viral inhibition against both the strains. All extracts inhibited the enzymatic activity of viral neuraminidase and four extracts were also shown to act through the hemagglutination inhibition (HI) pathway. Moreover, the samples that acted through both HI and neuraminidase inhibition (NI) evidenced more than 90% reduction in virus adsorption and penetration, thereby indicating potent action in the early stages of viral replication. Concurrent studies involving Receptor Destroying Enzyme treatments of HI extracts indicated the presence of sialic acid-like component(s) that could be responsible for hemagglutination inhibition. The manifestation of both modes of viral inhibition in a single extract suggests that there may be a synergistic effect implicating more than one active component. Overall, our results provide substantive support for the use of Borneo traditional plants as promising sources of novel anti-influenza drug candidates. Furthermore, the pathways involving inhibition of hemagglutination could be a solution to the global occurrence of viral strains resistant to neuraminidase drugs.

RETRACTED ARTICLE: Interferon-mediated antiviral activities of Angelica tenuissima Nakai and its active components

“…As an example, influenza viruses are highly infectious and constitute a major causative agent for recurrent epidemics and pandemics. On average, approximately 10% of the world's population is infected by the virus annually, resulting in an estimated 250,000 deaths, hence posing a serious health threat (Rajasekaran et al, 2013). Moreover, new and re-emerging infectious viral diseases are a rising global health threat, and the risk of spreading these viruses between continents and countries is even greater.…”

Screening of ethnic medicinal plants of South India against influenza (H1N1) and their antioxidant activity

“…Viruses are one of the major infective agents causing various health problems to humans resulting in death every year (Rajasekaran et al, 2013). Among the viral diseases influenza plays a vital role in humans and animals causing serious illness and major financial strain/stress.…”

A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms

“…Present review reported plant extracts likely to be promising candidates in the race of developing thirdgeneration anti-influenza drugs, thus challenging the neuraminidase drug-resistant viruses in an effort to protect human health and the global economy. [49] Present review showed that the Himalayan plants contain several bioactive substances like monoterpenoids, flavonoids, triterpenoids, iridoid glycosides, sesquiterpenes, benzoic and phenolic compounds having strong antiviral activity. Among traditionally used medicinal plants of the Himalayan region, phytochemicals of only four plants (Justicia adhatoda, Ocimum basilicum, Plantago major and Zingiber officinale) have been directly checked against viral pathogens ( Table 2).…”